Literature DB >> 7522998

Association of pancreatic adenocarcinoma, mild lung disease, and delta F508 mutation in a cystic fibrosis patient.

G J Tsongalis1, G Faber, F G Dalldorf, K J Friedman, L M Silverman, J R Yankaskas.   

Abstract

A case of adenocarcinoma of the pancreas and mild lung disease in a 39-year-old man homozygous for the delta F508 cystic fibrosis mutation is presented. Cystic fibrosis is the most common lethal genetic disease in Caucasians, and is most commonly associated with severe obstructive lung disease. To our knowledge, this is only the fifth case of adenocarcinoma of the pancreas in a CF patient to be reported and the first case for which molecular data are available. The rare incidence of this type of malignancy in the general population suggests a possible association of CF with this malignant disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522998

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

1.  Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis.

Authors:  M Srivastava; O Eidelman; H B Pollard
Journal:  Mol Med       Date:  1999-11       Impact factor: 6.354

Review 2.  Risk of pancreatic cancer in patients with cystic fibrosis.

Authors:  P Maisonneuve; B C Marshall; A B Lowenfels
Journal:  Gut       Date:  2007-09       Impact factor: 23.059

3.  Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma.

Authors:  Robert R McWilliams; Gloria M Petersen; Kari G Rabe; Leonard M Holtegaard; Pamela J Lynch; Michele D Bishop; W Edward Highsmith
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

Review 4.  Emerging role of cystic fibrosis transmembrane conductance regulator - an epithelial chloride channel in gastrointestinal cancers.

Authors:  Yuning Hou; Xiaoqing Guan; Zhe Yang; Chunying Li
Journal:  World J Gastrointest Oncol       Date:  2016-03-15

Review 5.  Subject review: pancreatic ductal adenocarcinoma in the setting of mutations in the cystic fibrosis transmembrane conductance regulator gene: case report and review of the literature.

Authors:  David W Rittenhouse; Vanessa A Talbott; Zafia Anklesaria; Jonathan R Brody; Agneszkia K Witkiewicz; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2011-08-02       Impact factor: 3.452

Review 6.  Unique presentations and chronic complications in adult cystic fibrosis: do they teach us anything about CFTR?

Authors:  M P Boyle
Journal:  Respir Res       Date:  2000-11-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.